{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:15:57Z","timestamp":1788477357334,"version":"build-2803163510"},"reference-count":43,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2019,12,2]]},"DOI":"10.1080\/13543784.2019.1694000","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:15:32Z","timestamp":1573776932000},"page":"1041-1049","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":40,"title":["DNX-2401: an investigational drug for the treatment of recurrent glioblastoma"],"prefix":"10.1080","volume":"28","author":[{"given":"Brandon","family":"Philbrick","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Emory University School of Medicine","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Adamson","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Emory University School of Medicine","place":["Atlanta, USA"]},{"name":"Neurosurgery Section, Atlanta VA Medical Center","place":["Decatur, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,11,22]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543780903052764"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2015.1048332"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043330"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.3171\/2015.4.JNS142200"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S6852"},{"key":"e_1_3_5_8_1","first-page":"39","article-title":"Glioblastoma multiforme oncogenomics and signaling pathways","volume":"3","author":"Kanu OO","year":"2009","unstructured":"Kanu OO, Hughes B, Di C, et al. Glioblastoma multiforme oncogenomics and signaling pathways. Clin Med Oncol. 2009 Apr 8;3:39\u201352. PubMed PMID: 19777070; PubMed Central PMCID: PMCPMC2748278.","journal-title":"Clin Med Oncol"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2016.04.007"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos273"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.2174\/157016312803305915"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-014-0380-6"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10120492"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2013.01.007"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-015-1802-5"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.3727\/096504016X14612603423511"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.8721"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1308345"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1308573"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noy170"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2019.1572112"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/95.9.652"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.891601"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.2174\/156652309789753356"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-4781(02)00249-X"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5304.1320"},{"issue":"3","key":"e_1_3_5_27_1","first-page":"265","article-title":"Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins","volume":"13","author":"Koivunen E","year":"1995","unstructured":"Koivunen E, Wang B, Ruoslahti E. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Biotechnology (N Y). 1995 Mar;13(3):265\u2013270. PubMed PMID: 9634769.","journal-title":"Biotechnology (N Y)"},{"issue":"2","key":"e_1_3_5_28_1","first-page":"380","article-title":"Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery","volume":"49","author":"Bello L","year":"2001","unstructured":"Bello L, Francolini M, Marthyn P, et al. Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery. Neurosurgery. 2001 Aug;49(2):380\u2013389 discussion 390. . PubMed PMID: 11504114.","journal-title":"Neurosurgery"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm102"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097407"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1590"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature05236"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.4161\/auto.5260"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2014.452"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25774"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2018.11.020"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-5312"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02032-10"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0468"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuros\/nyy504"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3536"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mt.6300400"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi113"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.8219"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4663"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2019.1694000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T19:17:41Z","timestamp":1770405461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2019.1694000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,22]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12,2]]}},"alternative-id":["10.1080\/13543784.2019.1694000"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2019.1694000","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-08-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}